Humana announced improved CMS Star Ratings for 2027, with 95 percent of its Medicare Advantage members enrolled in plans rated 4.0 stars or above and 42 percent in 4.5-star plans. For 2027, Humana has six Medicare Advantage contracts rated 4.5 stars and 12 rated 4.0 stars, an increase of 11 contracts rated 4.0 stars or above compared with the prior year, while its stand-alone prescription drug plan contract earned a 4.5-star rating. The company said performance improved across all measure categories, with 663,000 more care opportunities met and 534,000 additional members completing an annual preventive visit versus the prior year. Those engagement efforts produced 28,000 overdue mammograms that identified 600 previously undetected breast cancers, 93,000 overdue colorectal cancer screenings that identified 100 previously undetected precancers and cancers, and 73,000 overdue eye exams for members with diabetes that identified 17,000 previously undetected diagnoses of diabetes-related eye disease. CEO Jim Rechtin said the ratings reflect the work of thousands of Humana employees, and Chief Medical Officer Shantanu Nundy said earlier detection gives members more treatment options and better outcomes.
Humana IncHumana's CMS Star Ratings improved for 2027, with 95% of Medicare Advantage members in 4-star or above plans, boosting quality bonus eligibility.
